claim
Clearance of senescent cells (SCs) and decreasing the senescence-associated secretory phenotype (SASP) benefit organ repair and disease treatment, but senolytics often have poor cell selectivity that may damage normal tissue, and SASP inhibitors targeting specific secretory factors have limited therapeutic effects on multiple factors-mediated diseases.

Authors

Sources

Referenced by nodes (3)